Can Topiramate (Topamax) Help You Lose Weight?

Can Topiramate (Topamax) Help You Lose Weight?

Can Topiramate (Topamax) Help You Lose Weight?
Adobe Stock
The U.S. Food and Drug Administration (FDA) has approved topiramate (Topamax) for treating epilepsy and preventing migraines. Healthcare professionals also use it off-label to help people lose weight. In combination with a drug called phentermine, it’s also prescribed and FDA-approved for weight loss as Qsymia.

While topiramate doesn’t have FDA approval as a weight loss drug on its own, multiple clinical studies have shown that it can be effective for this purpose.



Does Off-Label Topiramate Support Weight Management?

Several studies have demonstrated how topiramate can help with weight loss. One randomized controlled trial compared topiramate to a placebo in 385 patients ages 18 to 75 with a body mass index (BMI) between 30 and 50. The patients who were given topiramate took four doses ranging between 64 and 384 milligrams. The study found that all four doses led to significant weight loss compared with the placebo group, with higher doses corresponding to greater weight loss. Research has also shown it to be well tolerated, causing few side effects.

Ann Rogers, MD, a bariatric surgeon and weight loss expert at Penn State Health in Middletown, Pennsylvania, says that off-label drug use isn’t uncommon. This means that a doctor has decided that there is a good reason to use the drug for a purpose other than its FDA-approved use.

“Doctors will find out that certain medications do certain things effectively, and then will start using them for that purpose,” Dr. Rogers says. “Part of the reason that topiramate may not be FDA-approved for weight loss is that although research has found that it can be effective, researchers don’t yet fully understand how it achieves this weight loss effect.”

A doctor might prescribe topiramate for weight loss if other options haven’t worked, have led to severe side effects, or are too costly for the patient, she adds.

“It all comes down to what insurance will cover, what works, and what the patient can afford,” Rogers says. “If a patient also lives with migraine, a doctor might choose topiramate to try to achieve both effects with a single medication.”

How Much Weight Do People Lose on Topiramate?

In the best-case scenario, Rogers says, a person taking topiramate might lose 5 to 8 percent of their body weight over the course of a year. For example, one long-term study found that patients taking 256 milligrams of topiramate per day achieved a mean weight decrease of 9.7 percent, which persisted for up to 60 weeks.

Weight loss on topiramate is generally slow, Rogers notes. This may not be a downside: People who lose weight rapidly may be more prone to health risks and weight regain than those who lose weight more slowly and sustainably.

Studies of topiramate often involve people with a BMI of 27 or higher. Research has not assessed its effectiveness in people with a lower BMI or those under 18 years of age.

How Can Taking Topiramate Lead to Weight Loss?

The specific mechanism of topiramate weight loss isn’t clear. However, several theories have tried to explain how it may help to facilitate weight loss. Some of the most common proposed mechanisms include:

  • Altering Metabolism A leading theory suggests that topiramate changes the way the body uses energy, which can cause increased fat burning. Researchers have also observed that it can lower fasting blood glucose, triglycerides, and low-density lipoprotein (LDL, or “bad”) cholesterol, while increasing levels of high-density lipoprotein (HDL, or “good”) cholesterol. This could also support weight loss by improving metabolism.
  • Altering Reward Pathways Topiramate may alter food-related reward pathways in the brain, nervous system, and hormonal system. This may help to improve a person’s appetite control.
  • Loss of Taste Taste impairment is a known side effect of topiramate and may contribute to weight loss by making certain foods less desirable.

More research could help confirm the mechanism by which topiramate supports weight management. In the meantime, its use for weight loss will remain off-label.

Topiramate and Combination Therapy: Is It Safe?

Drug producers have combined topiramate with phentermine under the name Qsymia, an FDA-approved weight loss medication that is an extended-release formulation of the two drugs. Qsymia is more effective than topiramate or phentermine alone.

However, Rogers notes that phentermine is technically a kind of amphetamine, which is a controlled substance that may pose a risk of abuse in some people. It may not be suitable for everyone who requires weight loss support.

Side Effects and Risks of Topiramate

The side effects of topiramate commonly include the following:

  • Blurred vision
  • Skin sensations, including burning, prickling, or tingling
  • Unsteadiness or clumsy movements
  • Confusion
  • Continuous, uncontrolled eye movements, including rolling the eyes and moving them back and forth
  • Dizziness
  • Double vision
  • Feeling lethargic
  • Red or painful eyes
  • Increase pressure in the eyes
  • A general increase in mental and physical sluggishness
  • Memory issues
  • Changes to the menstrual cycle
  • Menstrual pain
  • Increased nervousness
  • Changes to speech or language
  • Concentrating or attention issues
  • Fatigue
  • Weakness

A range of less common side effects can also occur, including:

  • Mood changes, including aggression, agitation, irritability, feeling low, or reduced emotions overall
  • Chest pain
  • Fever and chills
  • Red, bleeding, or irritated gums
  • Stomach pain
  • Sleep issues

Rarely, topiramate can cause changes to or issues with urination, such as:

  • Reduced bladder control
  • Peeing more often
  • Blood in the urine
  • Increased pain or difficulty while peeing

It can also rarely lead to:

  • Breathing problems
  • Swelling
  • Pale skin
  • Nosebleeds
  • Side or lower back pain
  • Itching or a skin rash
  • Hearing loss

Other side effects are possible. Talk to your healthcare professional if you experience unwanted physical changes after you start to take topiramate.

Stopping topiramate rapidly can be dangerous for people with epilepsy, as it can increase the risk of seizures happening again or increase how often seizures happen. It’s best to taper off antiepileptic medications, rather than abruptly stopping use.

 Even in people who aren’t taking topiramate to treat epilepsy, such as those receiving it off-label for weight management, suddenly stopping topiramate use requires careful judgment and monitoring by a healthcare professional.

Is It Safe to Lose Weight Quickly?

Losing weight too quickly can result in dehydration and gallstones. Health authorities generally consider one to two pounds of weight loss per week to be safe. They don’t recommend losing weight faster than that.

 However, taking topiramate does not lead to rapid or unsafe weight loss.

Rogers says that it’s critical to get plenty of protein and hydration while losing weight to avoid adverse effects.

The Takeaway

  • Topiramate is an FDA-approved drug for treating epilepsy and preventing migraines that doctors sometimes prescribe off-label to promote weight loss.
  • Studies report slow weight loss of 5 percent to more than 9 percent, depending on the dose a person takes, although how it works isn’t yet clear.
  • Topiramate is generally well tolerated, but it can cause a range of side effects in some people and is a neurological medication that needs a specialist prescription.
  • If you want to stop taking topiramate, speak to a clinician about tapering and monitoring, as rapid cessation can be dangerous for people taking it for its labeled use.

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Wajid I et al. Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review. Life (Basel). August 2023.
  2. Understanding Unapproved Use of Approved Drugs “Off Label”. U.S. Food and Drug Administration. February 5, 2018.
  3. Diet for Rapid Weight Loss. MedlinePlus. May 20, 2024.
  4. Yanovski SZ et al. Approach to Obesity Treatment in Primary Care: A Review. JAMA Internal Medicine. July 1, 2024.
  5. Topamax (Topiramate) Tablets, for Oral Use. U.S. Food and Drug Administration.
  6. Calorie Counting Made Easy. Harvard Health Publishing. April 3, 2024.

Diala Alatassi, MD, FACP

Medical Reviewer

Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care. By integrating medical expertise with a supportive and motivational approach, Dr. Alatassi fosters a partnership with each patient, guiding them with empathy and respect, to ensure they feel confident and capable of making lasting changes for their overall well-being.

In her free time, she enjoys spending time outdoors with family and friends and traveling.

Ajai Raj

Author
Ajai Raj is a reporter specializing in medical science, health, and technology. His work has appeared in Popular Science, Scientific American Mind, The Scientist, and the New York Daily News, as well as a number of medical trade journals.